首页> 外国专利> methods for generating antigen-loaded dendritic cells and for eliciting an immune response in a mammal; and, preservative composition.

methods for generating antigen-loaded dendritic cells and for eliciting an immune response in a mammal; and, preservative composition.

机译:在哺乳动物中产生负载抗原的树突细胞并引发免疫应答的方法;以及防腐剂成分。

摘要

methods for generating antigen-loaded dendritic cells and for eliciting an immune response in a mammal; and, preservative composition. The present invention provides compositions and methods for generating and cryopreserving dendritic cells with superior functionality in producing stronger t-cell signals, resulting in a more potent dc-based antitumor vaccine. The present invention includes mature, antigen-loaded toll-equivalent receptor-activated antigen-activated dcs that induce clinically effective immune responses, preferably when used more in the early course of the disease process. The DNAs of the present invention produce desirable levels of cytokines and chemokines, yet have the ability to induce apoptosis of tumor cells. The cells may be cryopreserved and thawed for later use, thereby reducing the need for repeated apheresis and elutriation processes during vaccine production. These methods can also be used to directly target target molecules involved in carcinogenic signaling pathways and cancer stem cells.
机译:在哺乳动物中产生负载抗原的树突细胞并引发免疫应答的方法;以及防腐剂成分。本发明提供了用于产生和冷冻保存树突细胞的组合物和方法,所述树突细胞在产生更强的t细胞信号中具有优越的功能,从而产生更有效的基于dc的抗肿瘤疫苗。本发明包括成熟的,载有抗原的费当量受体激活的抗原激活的dcs,其诱导临床上有效的免疫反应,优选在疾病过程的早期使用更多时。本发明的DNA产生所需水平的细胞因子和趋化因子,但具有诱导肿瘤细胞凋亡的能力。可以将细胞冷冻保存并融化以备后用,从而减少了疫苗生产过程中重复的血液分离和淘析过程的需要。这些方法还可用于直接靶向致癌信号通路和癌症干细胞中涉及的靶分子。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号